Analyst Ratings for Revance Therapeutic (rvnc)

rvnc Rating Summary

  |   Expand Research on rvnc
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.2 / 10   Percentile Rank: 17%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/16/2024 Barclays
» Updated 12/23/2024		 Balaji Prasad Downgrade Equalweight
(Overweight)		 3.00
(7.00)		 6.56
(3.65)		 -44.36% Details
8/13/2024 H.C. Wainwright Douglas Tsao Downgrade Neutral
(Buy)		 N/A
(N/A)		 6.60
(3.65)		 -44.7% Details